{"hands_on_practices": [{"introduction": "A cornerstone of medical genetics is the ability to predict the likelihood of disease transmission. This practice focuses on the most common inheritance pattern in Charcot-Marie-Tooth disease, autosomal dominance. By applying Mendelâ€™s law of segregation to a typical counseling scenario, you will calculate the fundamental recurrence risk, a critical skill for patient education and family planning. [@problem_id:4484654]", "problem": "A couple seeks counseling regarding the risk that their future child will have Charcot-Marie-Tooth disease type 1A (CMT1A). One parent is clinically affected with CMT1A caused by a heterozygous duplication of the peripheral myelin protein 22 (*PMP22*) gene on chromosome 17. The other partner is clinically unaffected and has no personal or family history of CMT. Assume the following foundational genetic principles and conditions hold:\n\n- Autosomal dominant inheritance: a single duplicated *PMP22* allele is sufficient to cause the CMT1A phenotype.\n- Law of segregation in meiosis: each gamete from a heterozygous parent carries either the duplicated allele or the normal allele with equal probability.\n- Full penetrance: the probability that an individual with at least one duplicated *PMP22* allele expresses the phenotype is $f=1$.\n- No de novo events: the probability that a new *PMP22* duplication arises in a gamete from the unaffected partner or post-zygotically is $d=0$.\n- The affected parent is heterozygous for the duplication, and the unaffected partner does not carry the duplication.\n\nUsing these assumptions and starting from the definitions of autosomal dominant transmission, the law of segregation, and penetrance, derive the recurrence risk that a single offspring of this couple will be clinically affected with CMT1A. Express your final answer as a decimal fraction. No rounding is required.", "solution": "The scenario involves autosomal dominant transmission with full penetrance and no de novo events. Let the duplicated *PMP22* allele be denoted by $A$ and the normal allele by $a$. The affected parent is heterozygous, with genotype $A a$, and the unaffected partner is homozygous normal, with genotype $a a$.\n\nBy the law of segregation, each gamete from the heterozygous parent carries either allele $A$ or allele $a$ with equal probability. Therefore, the probability that the affected parent transmits the duplicated allele is\n$$\nP(\\text{transmit } A) = \\frac{1}{2}.\n$$\nThe unaffected partner can only contribute the normal allele $a$ because they are $a a$ and there are no de novo events. Thus, the possible offspring genotypes and their probabilities are:\n- $A a$ with probability $\\frac{1}{2}$,\n- $a a$ with probability $\\frac{1}{2}$.\n\nUnder autosomal dominant inheritance and full penetrance $f=1$, any child with genotype $A a$ will be clinically affected, and any child with genotype $a a$ will be unaffected. Therefore, the recurrence risk $R$ that an offspring is affected equals the probability that the offspring inherits the duplicated allele multiplied by the penetrance:\n$$\nR = P(\\text{inherit } A) \\times f = \\left(\\frac{1}{2}\\right) \\times 1 = \\frac{1}{2}.\n$$\nSince $d=0$ (no de novo events), there is no additional contribution to risk from new duplications arising in the unaffected partner or post-zygotically. Thus, the final recurrence risk is\n$$\nR = 0.5.\n$$\nExpressed as a decimal fraction, the risk is $0.5$.", "answer": "$$\\boxed{0.5}$$", "id": "4484654"}, {"introduction": "After establishing genetic risk, diagnosis relies on linking the genetic cause to a measurable physiological effect. This exercise demonstrates how to compute nerve conduction velocity (NCV) from raw electrophysiological data, a key diagnostic measure in neuropathies. It further challenges you to integrate this finding with genetic information to correctly classify the disease subtype, bridging the gap between genotype and phenotype. [@problem_id:4484665]", "problem": "A patient with genetically confirmed Charcot-Marie-Tooth disease (CMT) undergoes motor median nerve conduction testing across a short forearm segment. The inter-stimulation distance between the distal wrist site and the proximal forearm site is measured as $d=80$ $\\mathrm{mm}$. The recorded difference in onset latencies between the proximal and distal stimulations (proximal minus distal) for the compound muscle action potential is $t=4.0$ $\\mathrm{ms}$. Using the core physical definition that velocity equals path length divided by transit time, determine the segmental conduction velocity for this median nerve forearm segment. Express your answer in $\\mathrm{m/s}$ and round your result to three significant figures.\n\nGenetic testing reveals a pathogenic variant in Mitofusin 2 (*MFN2*), a gene known to cause an axonal subtype of CMT. For the purposes of this problem, encode the Charcot-Marie-Tooth subtype as an integer $s$, defined as $s=1$ for demyelinating Charcot-Marie-Tooth type $1$ and $s=2$ for axonal Charcot-Marie-Tooth type $2$. Based solely on the genetic result, assign the appropriate $s$.\n\nReport your final output as a two-entry row vector $\\begin{pmatrix} v  s \\end{pmatrix}$, where $v$ is the conduction velocity in $\\mathrm{m/s}$ (rounded to three significant figures) and $s$ is the encoded subtype as defined above.", "solution": "The problem presents two distinct tasks. The first is to calculate the segmental motor nerve conduction velocity in a patient. The second is to classify the subtype of Charcot-Marie-Tooth disease based on a provided genetic result. I will address each task sequentially.\n\n**Part 1: Calculation of Segmental Conduction Velocity ($v$)**\n\nThe problem states that the conduction velocity, which we denote as $v$, is defined as the path length divided by the transit time. The path length is the inter-stimulation distance, $d$, and the transit time is the difference in onset latencies between the proximal and distal stimulation sites, $t$. This relationship is expressed by the formula:\n$$v = \\frac{d}{t}$$\n\nThe given values are:\n- Inter-stimulation distance: $d = 80$ $\\mathrm{mm}$\n- Difference in onset latencies: $t = 4.0$ $\\mathrm{ms}$\n\nThe final answer for the velocity must be in units of meters per second ($\\mathrm{m/s}$). Therefore, the given values for distance and time must be converted to the base SI units of meters ($\\mathrm{m}$) and seconds ($\\mathrm{s}$), respectively.\n\nFirst, we convert the distance $d$ from millimeters ($\\mathrm{mm}$) to meters ($\\mathrm{m}$):\n$$1 \\mathrm{m} = 1000 \\mathrm{mm}$$\n$$d = 80 \\mathrm{mm} \\times \\frac{1 \\mathrm{m}}{1000 \\mathrm{mm}} = 80 \\times 10^{-3} \\mathrm{m} = 0.080 \\mathrm{m}$$\n\nNext, we convert the time $t$ from milliseconds ($\\mathrm{ms}$) to seconds ($\\mathrm{s}$):\n$$1 \\mathrm{s} = 1000 \\mathrm{ms}$$\n$$t = 4.0 \\mathrm{ms} \\times \\frac{1 \\mathrm{s}}{1000 \\mathrm{ms}} = 4.0 \\times 10^{-3} \\mathrm{s} = 0.0040 \\mathrm{s}$$\n\nNow we can substitute these converted values into the velocity formula:\n$$v = \\frac{0.080 \\mathrm{m}}{0.0040 \\mathrm{s}} = \\frac{80 \\times 10^{-3} \\mathrm{m}}{4.0 \\times 10^{-3} \\mathrm{s}}$$\n\nThe factor of $10^{-3}$ in the numerator and denominator cancels out, simplifying the calculation:\n$$v = \\frac{80}{4.0} \\mathrm{m/s} = 20 \\mathrm{m/s}$$\n\nThe problem requires the result to be rounded to three significant figures. The calculated value is exactly $20$. To express this with three significant figures, we write it as $20.0$.\nThus, the conduction velocity is $v = 20.0$ $\\mathrm{m/s}$.\n\n**Part 2: Determination of the Subtype Encoding ($s$)**\n\nThe problem defines an integer encoding, $s$, for the subtype of Charcot-Marie-Tooth (CMT) disease:\n- $s = 1$ for demyelinating Charcot-Marie-Tooth type $1$ (CMT1)\n- $s = 2$ for axonal Charcot-Marie-Tooth type $2$ (CMT2)\n\nThe assignment of $s$ is to be based solely on the genetic result provided. The problem states that genetic testing reveals a pathogenic variant in the Mitofusin 2 (*MFN2*) gene.\n\nIn medical genetics and neurology, it is an established fact that pathogenic variants in the *MFN2* gene are the cause of Charcot-Marie-Tooth disease type 2A (CMT2A). CMT2A is the most common form of CMT type 2. CMT type 2 diseases are fundamentally characterized by primary axonal degeneration, as opposed to CMT type 1 diseases, which are characterized by primary demyelination.\n\nTherefore, the *MFN2* pathogenic variant corresponds to an axonal subtype of CMT. Based on the provided encoding scheme, axonal Charcot-Marie-Tooth type $2$ is encoded as $s=2$.\n\n**Final Answer Formulation**\n\nThe final output is required to be a two-entry row vector $\\begin{pmatrix} v  s \\end{pmatrix}$. Substituting the values determined above:\n- $v = 20.0$\n- $s = 2$\n\nThe resulting vector is $\\begin{pmatrix} 20.0  2 \\end{pmatrix}$.", "answer": "$$\n\\boxed{\n\\begin{pmatrix} 20.0  2 \\end{pmatrix}\n}\n$$", "id": "4484665"}, {"introduction": "Clinical classifications are often based on quantitative measurements, but these measurements are subject to inherent variability. This problem explores the practical consequences of such uncertainty, asking you to calculate the probability of misclassifying a patient due to measurement error. Tackling this challenge will enhance your understanding of how statistical principles are essential for interpreting diagnostic tests and appreciating their limitations. [@problem_id:4484627]", "problem": "In Charcot-Marie-Tooth disease (CMT), clinicians often dichotomize subtype by median Motor Nerve Conduction Velocity (MNCV). A common operational criterion classifies a median nerve recording as demyelinating if the observed MNCV is below a cutoff of $38\\,\\mathrm{m/s}$ and axonal otherwise. Consider an axonal case whose true MNCV is $40\\,\\mathrm{m/s}$. Suppose the measurement process has additive error with Standard Deviation (SD) $2\\,\\mathrm{m/s}$, and the observed velocities are modeled as normally distributed about the true value. Under this model, misclassification occurs when the observed velocity falls below the demyelinating cutoff despite the axonal physiology.\n\nStarting from the modeling assumptions that the observed velocity $V_{\\text{obs}}$ equals the true velocity $V_{\\text{true}}$ plus an additive error $\\epsilon$ and that $\\epsilon$ is Gaussian with mean $0$ and variance $\\sigma^{2}$, derive the probability that this axonal case is misclassified as demyelinating under the above cutoff. Express your final answer as a unitless decimal and round to four significant figures. Do not use a percentage sign.", "solution": "The problem asks for the probability of misclassifying an axonal case of Charcot-Marie-Tooth disease as demyelinating. The model for the observed median Motor Nerve Conduction Velocity ($V_{\\text{obs}}$) is given by the equation:\n$$V_{\\text{obs}} = V_{\\text{true}} + \\epsilon$$\nwhere $V_{\\text{true}}$ is the true velocity and $\\epsilon$ is an additive measurement error.\n\nThe given parameters are:\n-   The true velocity for the axonal case: $V_{\\text{true}} = 40 \\, \\mathrm{m/s}$.\n-   The cutoff for demyelinating classification: $V_{\\text{cutoff}} = 38 \\, \\mathrm{m/s}$.\n-   The measurement error $\\epsilon$ is a random variable following a Gaussian (normal) distribution with a mean of $\\mu_{\\epsilon} = 0 \\, \\mathrm{m/s}$ and a standard deviation of $\\sigma_{\\epsilon} = 2 \\, \\mathrm{m/s}$. The variance of the error is therefore $\\sigma_{\\epsilon}^2 = (2 \\, \\mathrm{m/s})^2 = 4 \\, (\\mathrm{m/s})^2$.\n\nSince $V_{\\text{true}}$ is a constant and $\\epsilon$ is a normally distributed random variable, $V_{\\text{obs}}$ is also a normally distributed random variable. We can determine its mean ($\\mu_{V}$) and variance ($\\sigma_{V}^2$).\n\nThe mean of the observed velocity is:\n$$\\mu_{V} = E[V_{\\text{obs}}] = E[V_{\\text{true}} + \\epsilon] = E[V_{\\text{true}}] + E[\\epsilon] = V_{\\text{true}} + \\mu_{\\epsilon}$$\nSubstituting the given values:\n$$\\mu_{V} = 40 + 0 = 40 \\, \\mathrm{m/s}$$\n\nThe variance of the observed velocity is:\n$$\\sigma_{V}^2 = \\text{Var}(V_{\\text{obs}}) = \\text{Var}(V_{\\text{true}} + \\epsilon) = \\text{Var}(\\epsilon) = \\sigma_{\\epsilon}^2$$\nSince adding a constant does not change the variance. Substituting the given value:\n$$\\sigma_{V}^2 = (2)^2 = 4 \\, (\\mathrm{m/s})^2$$\nThe standard deviation of the observed velocity is $\\sigma_V = \\sqrt{4} = 2 \\, \\mathrm{m/s}$.\n\nThus, the distribution of the observed velocity is normal with mean $\\mu_V = 40$ and standard deviation $\\sigma_V = 2$. We write this as $V_{\\text{obs}} \\sim N(\\mu_V=40, \\sigma_V^2=4)$.\n\nMisclassification occurs if the observed velocity $V_{\\text{obs}}$ is below the demyelinating cutoff, i.e., $V_{\\text{obs}}  38 \\, \\mathrm{m/s}$. We need to calculate the probability of this event, $P(V_{\\text{obs}}  38)$.\n\nTo calculate this probability, we standardize the random variable $V_{\\text{obs}}$ by transforming it into a standard normal variable $Z$, where $Z \\sim N(0, 1)$. The transformation is:\n$$Z = \\frac{V_{\\text{obs}} - \\mu_V}{\\sigma_V}$$\nApplying this transformation to the inequality:\n$$P(V_{\\text{obs}}  38) = P\\left(\\frac{V_{\\text{obs}} - \\mu_V}{\\sigma_V}  \\frac{38 - \\mu_V}{\\sigma_V}\\right)$$\nSubstituting the values of $\\mu_V = 40$ and $\\sigma_V = 2$:\n$$P\\left(Z  \\frac{38 - 40}{2}\\right) = P\\left(Z  \\frac{-2}{2}\\right) = P(Z  -1)$$\nThis probability is given by the cumulative distribution function (CDF) of the standard normal distribution, denoted as $\\Phi(z)$, evaluated at $z = -1$.\n$$P(Z  -1) = \\Phi(-1)$$\nUsing standard tables for the normal distribution or a computational tool, we find the value of $\\Phi(-1)$.\n$$\\Phi(-1) \\approx 0.15865525$$\nThe problem requires the answer to be a unitless decimal rounded to four significant figures.\n$$0.15865525 \\approx 0.1587$$\nTherefore, the probability that this axonal case is misclassified as demyelinating is approximately $0.1587$.", "answer": "$$\\boxed{0.1587}$$", "id": "4484627"}]}